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We report a case of necrotizing fasciitis with an accompanying toxic shock syndrome caused by Group G Streptococcus in a pedi-
atric patient with a lymphatic malformation. Pediatricians need to be aware of the possibility of such infections, especially in those
with vascular/lymphatic malformations, as early treatment is critical for survival.
1.Introduction
Necrotizing fasciitis (NF) is a potentially life-threatening soft
tissue infection that is characterized by necrosis of the fascia
and subcutaneous tissue and fat. The prognosis depends
uponaccuratediagnosisandearlysurgicaldebridement.This
is often diﬃcult due to the lack of initial physical signs. NF
is most common in immunocompromised hosts but may
also occur in healthy patients without apparent antecedent
injury. It is usually caused by either Group A streptococci or
a polymicrobial, synergistic infection. There are also emer-
ging monomicrobial causes, including those caused by non-
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a case of necrotizing fasciitis with an accompanying toxic-
shock syndrome caused by Group G Streptococcus in a pedi-
atric patient with a lymphatic malformation.
2.CaseReport
Thepatientwasa2-year-oldboywithahistoryofaprenatally
diagnosed vascular malformation with both lymphatic and
capillary components, involving the left retroperitoneum,
abdomen, pelvis, and thighs. He had had previous debulking
surgery soon after birth and another surgery in the ﬁrst year
of life to remove a lymphatic tumor that had developed over
the left buttocks. Since then, he had received multiple rounds
ofsclerotherapy.Therewasahistoryofthreepreviousadmis-
sions related to overlying cellulitis of the area and possible
infection of the malformation given increased swelling and
tenderness; although no organism had ever been cultured,
including ﬂuid aspirated from the mass. His ﬁrst admission
(1 year prior to this admission), was at an outside institution
and the patient was treated with ceftriaxone and then oral
ceﬁxime. During his second admission (4 months later),
the patient was initially treated with ampicillin/sulbactam,
vancomycin and gentamycin for anaerobic, Gram-positive,
and Gram-negative coverage. He was discharged home on
levoﬂoxacinforatotal of14 days.Onhis lastadmission prior
tothispresentation,thepatientwastreatedwithlevoﬂoxacin,
completing a 14-day course. He presented to the emergency
room (ER) on the day of the current admission with a 1-day
history of fever (Tmax 103.5) and 1 episode of vomiting.
The patient’s mother reported that his malformation had
increased in size and seemed more tender. The patient had
gone for scheduled sclerotherapy, but it was cancelled due
to the fever. In the ER, he was noted to be dehydrated and
his lymphangioma was tender throughout, particularly in
the perineum, but it was not erythematous. Complete blood
count revealed a white blood cell count (WBC) of 1.5 with
47% neutrophils, 14% bands, 26% lymphocytes, and 11%2 Case Reports in Medicine
monocytes. Platelets were 328 and hemoglobin and hemat-
ocrit were 11.9 and 36.1, respectively. The patient had previ-
ously had a normal white blood cell count. Erythrocyte sedi-
mentation rate (ESR) was 10, but C-reactive protein was 265.
He did not have hematuria, but urinalysis showed 1 + al-
bumin,traceketones,and3+blood.HewasgivenanIVﬂuid
bolus, started on levoﬂoxacin, and admitted to the hospital.
On hospital day 2 the patient was noted to be grunting
in pain with increased tenderness over the perineum, despite
a similar physical appearance of the malformation. On hos-
pital day 3 the patient developed a facial rash and peripheral
edema, as well as edema of the lower abdomen. His blood
pressure dropped to 70’s/40’s and he received crystalloid and
albumin. The infectious diseases service was consulted and
antibiotics werechanged to piperacillin/tazobactam and tob-
ramycin empirically for pseudomonas and to cover for any
organism with possible levoﬂoxacin resistance, given his pre-
vious treatment. The patient’s blood pressure dropped again
to 60’s/30’s. Laboratory values at the time revealed: D-Dimer
3.32, prothrombin time 23, international normalized ratio
1.93, partial thromboplastin time 44.5, sodium 131, bicar-
bonate 8, WBC 5.2, hematocrit 26.2, and platelets 50. The
patient was transferred to the pediatric intensive care unit
(PICU) for presumptive septic shock with respiratory dis-
tress and progressive edema. He was intubated on admission
to the PICU.
On hospital day 5 the patient had worsening edema and
erythema of the perineum. A CT scan was performed which
did not show any deﬁnite abscess, but he was taken to the
operatingsuitewherebilateralfasciotomiesanddebridement
ofnecrotictissueintheperineumwasperformed.Adiverting
colostomywasestablishedanddrainswereleftinplace.Chest
X-ray showed a large right pleural eﬀusion and a chest tube
was placed. Metronidazole was added to improve anaerobic
coverage.
On hospital day 7 the patient returned to the operating
room for further debridement. At this time he had clinda-
mycin added to his antibiotic regimen to combat a potential
“inoculum eﬀect” and in case there was toxin production.
IVIG2g/kgwasalsogiven,becausesignsandsymptomswere
consistent with a superimposed toxic shock picture. Conti-
nuous veno-venous hemoﬁltration (CVVH) and high-fre-
quency oscillating ventilation were initiated. Several days
later pure cultures of β hemolytic Streptococcus Group G,
S. dysgalactiae subspecies S. equisimilis was isolated from
wound and from stool. The stool culture was collected on
hospital day 1. The wound culture from the necrotic perineal
tissuewascollectedonhospitalday7afterhissecondsurgical
procedure. There was no susceptibility testing done and no
further typing of either sample.
The patient returned to the operating suite several times
for debridement, Broviac placement, and ultimately for
wound closure. Over the next 5 weeks he was weaned oﬀ
CVVH, the ventilator, and restarted on regular feeds. He
was ultimately treated with a six-week course of piperacillin/
tazobactam. It was felt that such a long duration of therapy
was necessary given the patient’s critical condition and his
multipletripstotheoperatingroom.Hewasdischargedafter
6w e e k s .
The patient’s father signed a HIPAA consent form autho-
rizing this case report.
3. Discussion
3.1. Necrotizing Fasciitis. Necrotizing fasciitis (NF) was des-
cribed in the 5th century BC by Hippocrates [1]. It has had
numerous appellations, including hospital gangrene, pha-
gedena gangrenosum, progressive bacterial synergistic gan-
grene, and Fournier’s gangrene [2]. The currently used term,
NF, was ﬁrst championed by Ben Wilson in 1952 as the most
descriptive of this infectious process [3]. The process is
marked by necrosis of the superﬁcial fascia, neutrophil inﬁl-
tration of the deep dermis and fascia, thrombosis of the
cutaneousmicrocirculation,andthepresenceoftheinfecting
organism in the necrotic tissue [2, 4, 5]. It must be distin-
guished from cellulitis, which lacks necrosis, and an abscess,
which is a localized purulence as compared to the diﬀuse
necrosis seen in NF [5]. These infections most often occur
on the extremities, abdomen, and in the perineum, but can
occur anywhere on the body [5].
NF is a relatively rare condition, with an incidence of 500
to 1500 reported cases caused by Group A Streptococcus per
year in the US [2, 6]. There are numerous risk factors, but
the immunocompromised are particularly susceptible. Some
of these conditions include diabetes mellitus, cancer (partic-
ularly chronic lymphocytic leukemia), HIV, peripheral vas-
cular diseases, renal or liver impairment, chronic corticos-
teroid use, chronic skin ulcers, recent surgery, and obesity
[5, 7]. NF usually starts at a site of trauma, often inapparent,
which may be a minor puncture wound, blunt trauma, or a
surgical scar [5].
NF can be divided into two distinct groups based upon
the causative organisms [2, 7, 8]. Type I is a polymicrobial
infection caused by non-Group-A Streptococci (including
Groups B, C, and G), aerobic organisms (including Enter-
obacter, E. coli, Klebsiella,a n dPseudomonas), and anaerobic
organisms (including Bacteroides and Clostridium). This
type is most often found in patients who are immunocom-
promised.TypeIIinfectionsareusuallycausedbyStreptococ-
cus pyogenes alone or with Staphylococci. These can occur in
individuals with no underlying comorbidities [2, 7, 8]. There
areothermonomicrobialinfectionsaswell,includingmarine
Vibrio supspecies (Gram-negative rods), usually associated
with sea water or marine animal exposure. Chronic liver
disease is a reported as a predisposing factor [9]. In addition,
there have been increasing numbers of infections caused
solely by non-Group A Streptococci [10–16].
In a study by Wong et al., the typical clinical presentation
of patients with NF was elucidated. Their patients usually
presented with exquisite pain, swelling, and fever. The only
initial signs wereoftentenderness,erythema,andwarmskin.
Additionally, pain out of proportion to clinical ﬁndings was
the most common initial symptom [2]. Other studies have
shown a ﬂu-like appearance during this initial stage [7].
Lymphangitis and lymphadenitis are not typically present
[7]. In Wong et al.’s study, an intermediate stage of NF was
characterized by the formation of small bullae [2]. The pre-
sence of such bullae ﬁlled with serous ﬂuid was an importantCase Reports in Medicine 3
Table 1: Patients with GGS necrotizing fasciitis (taken from [10–13, 17], and current report).
Age/sex Comorbidity Site Culture
source Therapy Outcome
75/F Syringomyelia L leg Tissue Antibiotics, debridement Survived
80/F None R leg Tissue Antibiotics, debridement Survived
(skin graft)
49/F None L ankle Tissue Antibiotics, debridement Survived
75/M None R leg Tissue Antibiotics, debridement Survived
71/M None L foot Skin/bulla Antibiotics, debridement Survived
(skin graft)
59/M Not stated R leg Skin/blister Antibiotics, debridement Died
64/F Diabetes mellitus Both legs Tissue Antibiotics Died
65/F Rheumatoid arthritis R arm Blood/tissue Antibiotics, amputation Died
52/M Diabetes mellitus R leg Tissue Antibiotics, debridement Survived
52/M Diabetes mellitus R leg Tissue Antibiotics, debridement Survived
59/M Hairy-cell leukemia L leg Blood/tissue Antibiotics, debridement Survived
58/M Cirrhosis L leg Tissue Antibiotics, debridement Died
49/F Rheumatoid arthritis R leg Blood/skin Antibiotics Died
48/M None R leg Tissue Antibiotics, debridement Survived
77/F Rheumatoid arthritis R leg Tissue/blood Antibiotics Died
2/M Vascular/lymphatic
malformation Perineum Tissue/stool Antibiotics, debridement Survived
diagnostic clue. Late signs for their patients included large
hemorrhagic bullae, skin necrosis, ﬂuctuance, crepitus, and
sensory and motor deﬁcits [2]. Children usually present with
fever, irritability, swelling of the aﬀected area, possibly ery-
thema, and pain out of proportion to clinical ﬁndings [17].
Withinfantsitmaybediﬃculttolocalizethepainwhileolder
children will tend to refuse to move the aﬀected site [17].
The management of NF begins with early recognition.
Unfortunately the diagnosis is often delayed due to a lack of
deﬁnitive signs and symptoms. Some have tried to develop
predictive tests for NF. Wong et al. propose a diagnostic scor-
ing system, LINEREC (laboratory risk indicator for necro-
tizing fasciitis) that is based on numerous laboratory tests,
including white cell count, electrolytes, and C-reactive pro-
tein which had a positive predictive value of 92.0% and neg-
ative predictive value of 96.0% [18]. More research needs to
be done to evaluate whether such systems will be of beneﬁt.
Other modalities such as frozen-section biopsy, CT, MRI,
and ultrasound can aid in diagnosis, but should never delay
operative intervention [4, 19–21]. Management consists of
early debridement, broad spectrum antibiotics against poly-
microbial infection (usually penicillin or ampicillin, plus
clindamycin, and an aminoglycoside), hemodynamic sup-
port, repeated examinations with debridement of the wound
(usually within 24–36h), and aggressive nutritional support
[22–24]. Additionally, cultures should be obtained from
blood and from the aﬀected tissue. Another treatment which
is still controversial is hyperbaric oxygen which may assist
healing and prevent amputation [25, 26]. Despite interven-
tion, necrotizing fasciitis has a mortality rate from 6 to
76%, with a review of 696 patients showing a rate of 34%
[22, 27]. In the study by Wong et al., the only factor that
was found to independently aﬀect survival on multivariate
logistic regression analysis was the delay in surgery [2]. This
has been reinforced by numerous studies that show that early
surgical debridement is associated with a signiﬁcant decrease
in mortality [23, 27, 28].
3.2. Group G Necrotizing Fasciitis. Group G Streptococci
(GGS)areapartofthenormalﬂoraofhumanskin,pharynx,
vagina, and gastrointestinal tract [29]. GGS are subdivided
by colony size and hemolytic phenotype [10]. Isolates that
produce large (≥5mm) β-hemolytic colonies are morpho-
logically similar to Group A Streptococcus and are classiﬁed
as S. dysgalactiae subspecies S. equisimilis [10, 29]. Group
G isolates that are small (≤5mm) have variable hemolytic
reactions and are classiﬁed within the Streptococcus milleri
or Streptococcus intermedius group [10, 29]. GGS are not
a common cause of bacteremia and have a relatively low
mortalityrateofabout8–16%[30,31].Otherassociatedsyn-
dromes include pharyngitis, skin and soft tissue infections,
pneumonia, septic arthritis, osteoarthritis, and endocarditis
[29]. While invasive disease due to GGS is rare, it has been
gaining increasing recognition in recent years. It usually
occurs in patients with debilitating conditions [30]. One
case, though, of neonatal sepsis caused by GGS in an infant
without any known risk factors has been reported [32].
Necrotizing fasciitis due to a monomicrobial infection with
GGS has been reported in 15 cases in the English literature
(Table 1)[ 10–13, 16].
The characteristics of the patients with GGS NF are very
similar to those with GAS NF. The patients with GGS NF
were often elderly with an average age of 62 among the 14
previously reported cases. The only child was our 2-year-old4 Case Reports in Medicine
patient. Ten patients had comorbid conditions, including
diabetes and rheumatoid arthritis. Four cases had preceding
trauma. The most common presenting signs and symptoms
were swelling with redness, pain, and blister formation.
The site of involvement was the leg in most cases, 1 case
in the arm, and 1 case in the perineum. The organism was
isolated from the site of involvement in all cases. All
patients were treated with antibiotics, including cefazolin,
cefazolin-clindamycin, piperacillin-tobramycin, penicillin-
gentamicin, penicillin-ﬂucloxacillin, piperacillin/tazobact-
am-tobramycin,carbapenem-minocycline, penicillin-clind-
amycin, and ﬂucloxacillin-gentamycin. Three patients recei-
ved IVIG. Debridement was used in 12 cases, amputation
in 1. Eight patients developed toxic shock syndrome. Toxic
shock syndrome (TSS) is a rare occurrence with GGS, and
its features and pathophysiology most likely are similar to
that of GAS TSS [33]. Six of the patients with TSS died.
Overall there were 6 deaths for a mortality of 40%. When
compared with Group A Streptococci, the only signiﬁcant
diﬀerence was in the site of involvement. GAS may involve
the extremities, trunk, or face while the patients with GGS
were mainly aﬀected in the lower extremities [11].
Our patient’s comorbid condition was a vascular/lym-
phatic malformation. Venous malformations do present a
known risk for streptococcal infection, even in otherwise
healthy children [34]. There has even been a reported case
of an arteriovenous malformation and necrotizing fasciitis
[35]. In this case, though, it was a pulmonary arteriovenous
malformation with resulting NF of the thigh. The mecha-
nism proposed for this was the formation of septic emboli.
In our patient, the malformation provided a direct nidus for
infection.
In summary, Group G Streptococcus is emerging as a
cause of invasive infections like necrotizing fasciitis and toxic
shock syndrome. The infections seem to follow a similar
coursetoinvasiveinfectionscausedbyGroupAStreptococci.
Clinicians need to be aware of the possibility of such infec-
tions as early treatment is critical for survival, especially in
childrenwithextensivevascularmalformations(agroupwho
mayhaveanincreasedriskoftheseinfectionssimilartoadult
patients with peripheral vascular disease).
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